BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15523918)

  • 21. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
    Norstrom EM; Mastrianni JA
    J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
    Prasad KN; Bondy SC
    Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion diseases and the 'protein only' hypothesis: a theoretical dynamic study.
    Laurent M
    Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):35-9. PubMed ID: 8761449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion seeded conversion and amplification assays.
    Orrú CD; Caughey B
    Top Curr Chem; 2011; 305():121-33. PubMed ID: 21678135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On safari with PrP: prion diseases of animals.
    Westaway D; Carlson GA; Prusiner SB
    Trends Microbiol; 1995 Apr; 3(4):141-7. PubMed ID: 7613755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
    Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
    FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond.
    Soto C; Saborio GP; Anderes L
    Trends Neurosci; 2002 Aug; 25(8):390-4. PubMed ID: 12127750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into prion structure and toxicity.
    Harris DA; True HL
    Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prion's elusive reason for being.
    Aguzzi A; Baumann F; Bremer J
    Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
    Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
    Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.